Vessel Co-option Is Common in Human Lung Metastases and Mediates Resistance to Anti-angiogenic Therapy in Preclinical Lung Metastasis Models

Bridgeman, Victoria L, Vermeulen, Peter B, Foo, Shane, Bilecz, Agnes, Daley, Frances, Kostaras, Eleftherios, Nathan, Mark R, Wan, Elaine +14 more·2017·The Journal of Pathology

Cited by (214)

Items 101–200 of 214

  1. Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways via off-VEGF signaling
    Xiaoling Zhang, Yan Zhang, Yanan Jia · 2020 · Cancer Biology and Medicine
  2. Pharmacogenetics implementation in the clinics: information and guidelines for germline variants
    Francesco Pezzella · 2019 · Cancer Drug Resistance
  3. Angiopoietin-1 Upregulates Cancer Cell Motility in Colorectal Cancer Liver Metastases through Actin-Related Protein 2/3
    Miran Rada, Audrey Kapelanski‐Lamoureux, Migmar Tsamchoe, Stephanie K. Petrillo, Anthoula Lazaris, Peter P. Metrakos · 2022 · Cancers
  4. Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma
    Serena Astore, Giulia Baciarello, Linda Cerbone, Fabio Calabrò · 2023 · Cancer Drug Resistance
  5. Machine-learning and mechanistic modeling of metastatic breast cancer after neoadjuvant treatment
    Sébastien Benzekry, Michalis Mastri, Chiara Nicolò, John M.L. Ebos · 2024 · PLoS Computational Biology
  6. Potential Therapeutic Strategies for Lung and Breast Cancers through Understanding the Anti-Angiogenesis Resistance Mechanisms
    Wafaa S.H. Ramadan, Dana M. Zaher, Alaa Muayad Altaie, Iman Mamdouh Talaat, Adel B. Elmoselhi · 2020 · International Journal of Molecular Sciences
  7. Improved Immunotherapy Efficacy by Vascular Modulation
    Emma Newport, Ana‐Rita Pedrosa, Alexandra Njegić, Kairbaan Hodivala‐Dilke, José M. Muñoz‐Félix · 2021 · Cancers
  8. The Dual Effect of the BMP9–ALK1 Pathway in Blood Vessels: An Opportunity for Cancer Therapy Improvement?
    Blanca Ayuso-Íñigo, Lucía Méndez-García, Miguel Pericacho, José M. Muñoz‐Félix · 2021 · Cancers
  9. Melanoma Tumour Vascularization and Tissue-Resident Endothelial Progenitor Cells
    Ghazaleh Hashemi, James Dight, Kiarash Khosrotehrani, Laura Sormani · 2022 · Cancers
  10. Hutchinson-Gilford Progeria Syndrome: Challenges at Bench and Bedside
    Ray Kreienkamp, Susana Gonzalo · 2019 · Sub-cellular biochemistry/Subcellular biochemistry
  11. Sequential deconstruction of composite drug transport in metastatic breast cancer
    Shreya Goel, Guodong Zhang, Prashant Dogra et al. · 2020 · Science Advances
  12. Inactivation of endothelial cell phosphoinositide 3-kinase β inhibits tumor angiogenesis and tumor growth
    Abul Kalam Azad, Pavel Zhabyeyev, Bart Vanhaesebroeck, Gary Eitzen, Gavin Y. Oudit, Ronald Brian Moore, Allan G. Murray · 2020 · Oncogene
  13. Perfusion Patterns of Peripheral Pulmonary Granulomatous Lesions Using Contrast‐Enhanced Ultrasound ( CEUS ) and Their Correlation with Immunohistochemically Detected Vascularization Patterns
    Ehsan Safai Zadeh, Corinna Ulrike Keber, Christoph Frank Dietrich, Christina Carolin Westhoff, Christina Günter, Björn Beutel, Amjad Alhyari, Corinna Trenker, Christian Görg · 2021 · Journal of Ultrasound in Medicine
  14. The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers
    Ying Shao, Bingjian Lü · 2021 · Cancer and Metastasis Reviews
  15. Metastasis prevention: targeting causes and roots
    Anastasia A. Schegoleva, Anna A. Khozyainova, Tatiana S. Gerashchenko, Lilia D. Zhuikova, Evgeny V. Denisov · 2022 · Clinical & Experimental Metastasis
  16. The molecular mechanisms underlying neutrophil infiltration in vessel co-opting colorectal cancer liver metastases
    Miran Rada, Nour Hassan, Anthoula Lazaris, Peter P. Metrakos · 2022 · Frontiers in Oncology
  17. Vascular Growth in Lymphomas: Angiogenesis and Alternative Ways
    Doménico Ribatti, Roberto Tamma, Tiziana Annese · 2023 · Cancers
  18. Gambogic acid suppresses nasopharyngeal carcinoma via rewiring molecular network of cancer malignancy and immunosurveillance
    Tao Ren, Xian-Yu Bai, Meng-Zhe Yang, Ning Xu, Xing-Zhe Guo, Liu-Jie Qin, Zhi-Lin Huang, Qiong-Yao Zhong, Yuan-Jiao Huang, Wen‐Zhen Lin et al. · 2022 · Biomedicine & Pharmacotherapy
  19. Age as key factor for pattern, timing, and extent of distant metastasis in patients with cutaneous melanoma: A study of the German Central Malignant Melanoma Registry
    Maximilian Gassenmaier, Ulrike Keim, Ulrike Leiter, Thomas Eigentler, Martin Röcken, Anja Gesierich, Rose K. C. Moritz, Lucie Heinzerling, Thomas Tüting, Uwe Wollina et al. · 2019 · Journal of the American Academy of Dermatology
  20. Molecular Mechanisms of Resistance to Anti-Angiogenic Drugs
    Arianna Filippelli, Valerio Ciccone, Sandra Donnini, Marina Ziche, Lucia Morbidelli · 2020 · Critical Reviews™ in Oncogenesis
  21. Off-tumor targets compromise antiangiogenic drug sensitivity by inducing kidney erythropoietin production
    Masaki Nakamura, Yin Zhang, Yunlong Yang et al. · 2017 · Proceedings of the National Academy of Sciences
  22. Resistance Mechanisms of the Metastatic Tumor Microenvironment to Anti-Angiogenic Therapy
    Lars Mortimer Schiffmann, Christiane J. Bruns, Thomas Schmidt · 2022 · Frontiers in Oncology
  23. Overcoming chemoresistance in non-angiogenic colorectal cancer by metformin via inhibiting endothelial apoptosis and vascular immaturity
    Guangyue Li, Shujing Zhang, Dong Qian Xue, Yue-Qi Feng, Yan Li, Xun Huang, Qiang Cui, Bo Wang, Jun Feng, Tao Bao et al. · 2023 · Journal of Pharmaceutical Analysis
  24. Accessing the vasculature in cancer: revising an old hallmark
    Adrian Llewellyn Harris, David James Kerr, Francesco Pezzella, Doménico Ribatti · 2024 · Trends in cancer
  25. The mechanistic immunosuppressive role of the tumour vasculature and potential nanoparticle-mediated therapeutic strategies
    Zakaria Elias Ileiwat, Tanveer Ahmad Tabish, Dmitry Aleksandrovich Zinovkin, Jale Yüzügülen, Nahid Arghiani, Md Zahidul Islam Pranjol · 2022 · Frontiers in Immunology
  26. Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer†
    Giovanna Armani, Denise Madeddu, Giulia Mazzaschi, Giovanni Bocchialini, Francesco Sogni, Caterina Frati, Bruno Lorusso, Angela Falco, Costanza Annamaria Lagrasta, Stefano Cavalli et al. · 2017 · European Journal of Cardio-Thoracic Surgery
  27. Blood Supply of Early Lung Adenocarcinomas in Mice and the Tumor-supplying Vessel Relationship: A Micro-CT Angiography Study
    Linhong Deng, Hanzhou Tang, Jinwei Qiang, Jie Wang, Shiman Xiao · 2020 · Cancer Prevention Research
  28. Perfusion Patterns of Peripheral Organizing Pneumonia (POP) Using Contrast-Enhanced Ultrasound (CEUS) and Their Correlation with Immunohistochemically Detected Vascularization Patterns
    Ehsan Safai Zadeh, Christina Carolin Westhoff, Corinna Ulrike Keber, Corinna Trenker, Christoph Frank Dietrich, Amjad Alhyari, Charlotte Gabriele Luise Mohr, Christian Görg · 2021 · Diagnostics
  29. Propensity for Early Metastatic Spread in Breast Cancer: Role of Tumor Vascularization Features and Tumor Immune Infiltrate
    Mario Rosario D'Andrea, Vittore Cereda, Luigi Coppola, Guido Giordano, Andrea Remo, Elena De Santis · 2021 · Cancers
  30. Stress in the metastatic journey – the role of cell communication and clustering in breast cancer progression and treatment resistance
    Eloïse M Grasset, S. Barillé-Nion, Philippe P. Juin · 2024 · Disease Models & Mechanisms
  31. Clinical implications and mechanism of histopathological growth pattern in colorectal cancer liver metastases
    Bingtan Kong, Qingsheng Fan, Xiaomin Wang, Qing Hua Zhang, Gan‐Lin Zhang · 2022 · World Journal of Gastroenterology
  32. The cellular and molecular mediators of metastasis to the lung
    Oliver Cucanic, Rae H. Farnsworth, Steven A. Stacker · 2022 · Growth Factors
  33. Lymphatics-associated genes are downregulated at transcription level in non-small cell lung cancer
    Oksana Kowalczuk, Jerzy Laudanski, Wojciech Laudański, Wieslawa Ewa Niklinska, Mirosław Kozłowski, Jacek Nikliński · 2018 · Oncology Letters
  34. Blood Vessel-Targeted Therapy in Colorectal Cancer: Current Strategies and Future Perspectives
    Jacobsen, Anne, Siebler, Jürgen, Grützmann, Robert, Stürzl, Michael, Naschberger, Elisabeth · 2024 · Cancers
  35. Upregulation of annexin A1 protein expression in the intratumoral vasculature of human non–small-cell lung carcinoma and rodent tumor models
    Kevin L. Allen, Jennifer A. Cann, Weiguang Zhao et al. · 2020 · PLoS ONE
  36. Anti-angiogenic therapy in ovarian cancer: current situation & prospects
    Yinping Liu, Yi Luo, Meiling Cai, Peijun Shen, Jun Li, Hailin Chen, Wei Bao, Yaping Zhu · 2021 · International Journal of Microbiology Research
  37. A CD276 Antibody Guided Missile with One Warhead and Two Targets: The Tumor and Its Vasculature
    Kabir A. Khan, Robert S. Kerbel · 2017 · Cancer Cell
  38. Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice
    Inga B. Fricke, Raquel De Souza, Laís Costa Ayub · 2018 · PLoS ONE
  39. Hypoxia as a signal for prison breakout in cancer
    Andrew David Redfern, Veenoo Agarwal, Erik W. Thompson · 2019 · Current Opinion in Clinical Nutrition & Metabolic Care
  40. Multi‐parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour‐type‐specific stroma phenotypes and a novel vascular biomarker
    Sara Corvigno, Magnus Frödin, G. Bea A. Wisman, Hans W. Nijman, Ate GJ van der Zee, Karin Jirström, Björn Nodin, Ina Hrynchyk, David Edler, Peter Ragnhammar et al. · 2017 · The Journal of Pathology Clinical Research
  41. Molecular characterization of the histopathological growth patterns of colorectal cancer liver metastases by RNA sequencing of targeted samples at the tumor-liver interface
    Emily Latacz, Sanne M L Verheul, Yasmine Sillis, Pieter‐Jan van Dam, Michail Doukas, Dirk Jan Grünhagen, Hanna Nyström, Piet R. Dirix, Luc Yves Dirix, Steven Van Laere et al. · 2024 · Clinical & Experimental Metastasis
  42. A novel second near-infrared theranostic agent: a win–win strategy of tracing and blocking tumor-associated vessels for oral squamous cell carcinoma
    Z. Wei, H. Zhang, Huihui Zou · 2022 · Materials Today Nano
  43. Dynamic Predictive Models with Visualized Machine Learning for Assessing the Risk of Lung Metastasis in Kidney Cancer Patients
    Chan Xu, Zhou Qian, Wencai Liu, Wenle Li, Shengtao Dong, Wanying Li, Xiaofeng Xu, Ximin Qiao, Youli Jiang, Jingfang Chen et al. · 2022 · Journal of Oncology
  44. Disruption of integrin alpha-5/beta-1-dependent transforming growth factor beta-1 signaling pathway attenuates vessel co-option in colorectal cancer liver metastases
    Miran Rada, Audrey Kapelanski‐Lamoureux, Oran Zlotnik, Stephanie K. Petrillo, Anthoula Lazaris, Peter P. Metrakos · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  45. Plasma vascular endothelial growth factor as a predictive biomarker: Door closed?
    Punam Rana, Kathleen I. Pritchard, Robert S. Kerbel · 2016 · European Journal of Cancer
  46. Preclinical impact of high dose intermittent antiangiogenic tyrosine kinase inhibitor pazopanib in intrinsically resistant tumor models
    Elaine Reguera-Nuñez, Shan Man, Ping Xu, Robert S. Kerbel · 2018 · Angiogenesis
  47. Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer
    Artur Mezheyeuski, Ina Hrynchyk, Mercedes Herrera, Mia Karlberg, Erik Osterman, Peter Ragnhammar, David Edler, Anna Portyanko, Fredrik Pontén, Tobias Sjöblom et al. · 2019 · British Journal of Cancer
  48. Anti-Angiogenic Therapy: Albumin-Binding Proteins Could Mediate Mechanisms Underlying the Accumulation of Small Molecule Receptor Tyrosine Kinase Inhibitors in Normal Tissues with Potential Harmful Effects on Health
    Nicolae Ghinea · 2021 · Diseases
  49. Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis
    Lidija Ljubičić, Urška Janžič, Mojca Unk, Ana Sophie Terglav, Katja Mohorčič, Fran Seiwerth, Lela Bitar, Sonja Badovinac, Sanja Pleština, Marta Koršić et al. · 2023 · Radiology and Oncology
  50. Inter-Metastatic Heterogeneity of Tumor Marker Expression and Microenvironment Architecture in a Preclinical Cancer Model
    Jessica Kalra, Jennifer H.E. Baker, Justin Song, Alastair Hugh Kyle, Andrew Ivor Minchinton, Marcel B. Bally · 2021 · International Journal of Molecular Sciences
  51. Micropapillary lung adenocarcinoma and micrometastasis
    Yang Qu, Rania Gaber Mohamed Aly, Yusuke Takahashi · 2017 · Journal of Thoracic Disease
  52. Vascular cell-matrix adhesion in development and cancer
    Christina Arapatzi, Georgia Rouni, Vassiliki Kostourou · 2021 · The International Journal of Developmental Biology
  53. Angiotropism in recurrent cutaneous squamous cell carcinoma: Implications for regional tumor recurrence and extravascular migratory spread
    Faysal A. Fedda, Michael Robert Migden, Jonathan L. Curry, Carlos Antonio Torres-Cabala, Michael T. Tetzlaff, Phyu P. Aung, Victor Gerardo Prieto, Doina S. Ivan, Jeffrey N. Myers, Priyadharsini Nagarajan · 2018 · Journal of Cutaneous Pathology
  54. Basic fibroblast growth factor blockade enhances lung cancer cell invasion by activating the AKT/MMP‐2/VEGF pathway
    Zhiyong Wang, Huan Xu, Junai Zhang · 2019 · Basic & Clinical Pharmacology & Toxicology
  55. Personalized functional profiling using ex-vivo patient-derived spheroids points out the potential of an antiangiogenic treatment in a patient with a metastatic lung atypical carcinoid
    Hichul Kim, Victoria El‐Khoury, Nadine Schulte, Tianzuo Zhan, Johannes Betge, Loïc Cousin, Emanuele Felli, Patrick Pessaux, Arnaud Ogier, Oliver G. Opitz et al. · 2022 · Cancer Biology & Therapy
  56. Generation of vessel co-option lung metastases mouse models for single-cell isolation of metastases-derived cells and endothelial cells
    Anne Cuypers, Laure-Anne Marie Nicole Teuwen, Victoria Louise Bridgeman et al. · 2022 · STAR Protocols
  57. Potential application of [18F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma
    Bliede Van den Broeck, Jens M. Debacker, Wouter Bauters · 2024 · EJNMMI Research
  58. Resistance to Inhibitors of Angiogenesis
    Nili Dahan, Ksenia Magidey, Yuval Shaked · 2018 · Resistance to targeted anti-cancer therapeutics
  59. Role of (myo)fibroblasts in the development of vascular and connective tissue structure of the C38 colorectal cancer in mice
    Edina Bugyik, Vanessza Szabó, Katalin Dezső, András Rókusz, Armanda Szücs, Péter Nagy, József Tóvári, Viktória László, Balázs Döme, Sándor Paku · 2018 · 癌症:英文版
  60. Anti-angiogenic Therapy-Mediated Endothelial Damage: A Driver of Breast Cancer Recurrence?
    Laura Pisarsky, Cyrus Michael Ghajar · 2018 · Advances in experimental medicine and biology
  61. Vascular Disruption Therapy as a New Strategy for Cancer Treatment
    Jesús Gómez-Escudero, Patricia Berlana-Galán, Elena Guerra-Paes, Irene Torre-Cea, Laura Marcos-Zazo, Iván Carrera-Aguado, Daniel Cáceres-Calle, Fernando Sánchez‐Juanes, José M. Muñoz‐Félix · 2025 · International Journal of Molecular Sciences
  62. Neurovascular Interactions in the Development of the Vasculature
    Kazuhiro Takara, Yumiko Hayashi-Okada, Hiroyasu Kidoya · 2022 · Life
  63. Different types of tumor microvessels in stage I-IIIA squamous cell lung cancer and their clinical significance
    M. A. Senchukova, Evgeniy A Kalinin, Н. Н. Волченко · 2024 · World Journal of Clinical Oncology
  64. Endothelial dysfunction determines vascular mechanisms of metastatic progression in breast cancer
    Matluba Mirzaeva, Akbarjon Mirzayev, Bakhtiyar Iriskulov, Азимова Севара Бахадировна, Shamsiddin Nizamkhodjaev, Akmal M. Asrorov · 2026 · Discover Oncology
  65. Vascular adaptation to cancer beyond angiogenesis: The role of PTEN
    Sofia Ortiz Tamayo, Nelson Ivan Cupitra, Raúl Narváez-Sánchez · 2023 · Microvascular Research
  66. Modern ideas about the origin, features of morphology, prognostic and predictive significance of tumor vessels
    M. A. Senchukova, Е В Макарова, Evgeniy A Kalinin · 2019 · Russian Journal of Biotherapy
  67. Correction: Upregulation of annexin A1 protein expression in the intratumoral vasculature of human non–small-cell lung carcinoma and rodent tumor models
    Kevin L. Allen, Jennifer A. Cann, Weiguang Zhao et al. · 2021 · PLoS ONE
  68. Ultra‐High Frequency Ultrasound Imaging and Quantification of Microvascular Flow in Xenograft Renal Cell Carcinoma in an Avian Chorioallantoic Membrane Model
    Sara Mar, Emmanuel Chérin, Justin Xu, David E. Goertz, Hon Sing Leong, Christine E. M. Demore · 2026 · Journal of Ultrasound in Medicine
  69. Nonangiogenic tumor growth
    Peter Vermeulen, Francesco Pezzella · 2020 · Elsevier eBooks
  70. Modeling Lymphoma Angiogenesis, Lymphangiogenesis, and Vessel Co-Option, and the Effects of Inhibition of Lymphoma–Vessel Interactions with an αCD20-EndoP125A Antibody Fusion Protein
    Christian Elledge, Yu Zhang, Seung-Uon Shin et al. · 2024 · Cells
  71. Biological barriers to cancer drug delivery, efficacy and cancer models
    Loutfy H. Madkour · 2019 · Elsevier eBooks
  72. Vascular Co-option in the Brain Tumor Microenvironment
    Sarah Wang, Andrew C. Dudley · 2022 · Springer eBooks
  73. Diagnostic challenge and survival analysis of pulmonary oligometastases and primary lung cancer in breast cancer patients
    Siyao Mai, Haiqing Liu, Hong Zeng · 2024 · Thoracic Cancer
  74. Reprogramming tumor angiogenesis in breast cancer: Mechanisms, challenges, and future directions
    Barnalee Mishra, Suryendu Saha, Kavita Kumari, Samikshya Mahapatra, Sinjan Khanra, Diksha Malhotra, Gopal C. Kundu · 2026 · Biochemical and Biophysical Research Communications
  75. Integrin inhibition differentially remodels vascular networks in lung metastases driven by vessel co-option or angiogenesis
    Laura Marcos-Zazo, Iván Carrera-Aguado, Jesús Gómez-Escudero, Patricia Berlana-Galán, Irene Torre-Cea, Elena Guerra-Paes, Celia Redondo-Gonzalez, Juan Sánchez-Mateos, Daniel Cáceres-Calle, Óscar Maiques et al. · 2026 · Angiogenesis
  76. A transient MXD4-dependent proliferative pause enables survival of brain micrometastases
    Pedro García‐Gómez, Diana Retana, Carolina Hernández-Oliver, Oliva Sánchez, Neibla Priego, Laura Álvaro‐Espinosa, Lluís Cordón-Barris, Ana de Pablos-Aragoneses, Juan Vazquez-Canto, Andrea Rojas et al. · 2026 · Cancer Cell
  77. Mechanisms of Metastasis
    Sülen Sarıoğlu · 2018 · Springer eBooks
  78. Phase I studies assessing the safety and clinical activity of multiple doses of a NKG2D-based CAR-T therapy, CYAD-01, in metastatic colorectal cancer
    Anne Flament, Alain Hendlisz, Leila Shaza et al. · 2018 · Annals of Oncology
  79. Biology of Pericytes – Recent Advances: Role of Pericytes in Brain Metastasis
    Yoichi Morofuji, Shinsuke Nakagawa, Takashi Fujimoto, Susumu Yamaguchi, Kenta Ujifuku, Takayuki Matsuo · 2021 · Stem cell biology and regenerative medicine
  80. A Nomogram Incorporating Tumor-Related Vessels for Differentiating Adenocarcinoma In Situ from Minimally Invasive and Invasive Adenocarcinoma Appearing as Subsolid Nodules
    Linhong Deng, Han Zhou Tang, Jinwei Qiang · 2022 · Academic Radiology
  81. Time to Sleep: Immunologic Niche Switches Tumor Dormancy at Metastatic Sites
    Elaheh Nasrollahzadeh, Nima Rezaei · 2023 · Springer eBooks
  82. Exploring vasculogenesis in the normal human kidney and clear cell renal cell carcinoma: insights from development to tumor progression and biomarkers for therapy response
    Andrei Alexandru Cosma, Mihaela Pasca Fenesan, Alexandru Neşiu, Eugen Melnic, ADELA MARIA FERICIAN, Ovidiu Catalin Ferician, Emil Ceban, Simona Sârb, Anca Maria Cîmpean · 2024 · Frontiers in Oncology
  83. Morphological Features and Clinical Significance of Tumor Microvessels in Glandular and Squamous Cell Cancers
    M. A. Senchukova · 2024 · Interdisciplinary cancer research
  84. Vascular co-option
    Pedro García‐Gómez, Manuel Valiente · 2020 · Elsevier eBooks
  85. Comment on ‘Use the term “infiltrative” instead of “replacement” when defining histopathological growth pattern in patients with liver cancer’ by Kong B et al.
    Peter Vermeulen, Emily Latacz, Laura Hendrickx · 2023 · British Journal of Cancer
  86. Machine-learning and mechanistic modeling of primary and metastatic breast cancer growth after neoadjuvant targeted therapy
    Sébastien Benzekry, Michalis Mastri, C. Nicolò, John M.L. Ebos · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  87. Iterative Extracellular Vesicle Protein Co-Expression Biomarker Refinement for Preoperative Classification of Histopathological Growth Patterns in Colorectal Liver Metastasis Patients
    Rosalie Martel, Molly L. Shen, Migmar Tsamchoe, Stephanie K. Petrillo, Anthoula Lazaris, Peter P. Metrakos, David Juncker · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  88. Development of Orthotopic and Spontaneous Metastatic Human Tumor Xenograft Models for Experimental Therapeutics
    Marta Pàez‐Ribes, Raquel Muñoz, Éric Guérin, Shan Man, Ping Xu, John M.L. Ebos, Christina Lee, Andrew R. Reynolds, Yuval Shaked, Robert S. Kerbel · 2017 · Molecular and translational medicine
  89. Problem and Handling of Anti-angiogenic Therapy for Glioblastoma : Vessel Co-option and Vascular Mimicry
    Shingo Takano · 2018 · Japanese Journal of Neurosurgery
  90. The role of tunneling nanotubes in mediating intercellular communication in cancer
    Snider Desir · 2018 · University of Minnesota Digital Conservancy (University of Minnesota)
  91. Role of stromal Caveolin-1 in breast cancer angiogenesis
    Alberto Diez Sanchez · 2018
  92. Characterizing a regulatory axis of microRNA-200b, the RNA-binding protein quaking, and cyclin D1 in modulating tumor angiogenesis and metastasis
    Salma H. Azam · 2020 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  93. The Implication of Hypoxia and Cancer Stem Cells on Tumor Vasculogenesis
    Nermeen Moustafa · 2019 · American Journal of Biomedical Science & Research
  94. Investigating the role of G-protein coupled receptor (GPCR) signaling as a potential target for anti-angiogenic therapy
    Abul Kalam Azad · 2021 · ERA: Education and Research Archive (University of Alberta)
  95. Measurement of phi_s at LHCb
    S. Hansmann-Menzemer · 2010 · arXiv (Cornell University)
  96. Tumor-Vascular Interactions in Non-Small Cell Lung Cancer
    Maria Ramnefjell, Lars A. Akslen · 2022 · Springer eBooks
  97. Histopathological Patterns of Progression and Vessel Co-option
    Ève Simoneau, Peter P. Metrakos · 2022 · Springer eBooks
  98. Analysis of survival rates and evaluation of prognostic factors in patients with lung metastases from renal cell carcinoma
    Dmitry V. Semenov, Рашида Вахидовна Орлова, Валерий Иванович Широкорад, Кострицкий Станислав Викторович, N. A. Karlova · 2024 · Siberian Journal of Oncology
  99. Time to Sleep: Immunologic Niche Switches Tumor Dormancy at Metastatic Sites
    Elaheh Nasrollahzadeh, Nima Rezaei · 2025 · Springer eBooks
  100. Additional file 1 of The incorporation of acetylated LAP-TGF-β1 proteins into exosomes promotes TNBC cell dissemination in lung micro-metastasis
    Yu, Pei, Han, Yubao, Meng, Lulu, Zengying Tang, Zhiwei Jin, Zhang, Zhenzhen, Zhou, Yunjiang, Luo, Jun, Luo, Jianguang, Han, Chao et al. · 2024 · Figshare